Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » About Us » Our Staff » John Gilmore

John Gilmore

Staff Reporter
Phone Number
212-651-5628
Email
[email protected]

Articles Authored by John Gilmore

Mar 18, 2020

Nephrosant Eyes Launch of Urine-Based Kidney Transplantation Rejection Risk Assay

Premium

The San Francisco-based startup believes that its QiSant assay could help guide the use of immunosuppressive drugs and other therapies to prevent kidney transplant rejection.

Mar 12, 2020

University of Georgia Startup to Commercialize Ferrofluidic CTC Isolation Device

Premium

Through a startup called FCS Technology, the team is hoping to market the platform for cancer research and, eventually, clinical diagnostic applications. 

Mar 09, 2020

DermTech Trying to Drum up Payor Coverage for Melanoma Test With Study Results

Premium
Mar 05, 2020

Angle, BioView Demonstrate Integrated Workflow to Detect CTCs in Feasibility Study

Premium

The groups combined their circulating tumor cell collection and detection platforms to find higher cell numbers in metastatic breast, lung, and melanoma cancer patients. 

Feb 27, 2020

Karius to Widen Adoption, Improve Infectious Dx Technology With $165M Series B Funding

Premium

The firm argues that its tests allows hospitals to expedite patient treatment, while curbing the costs of one-off tests and medication, and minimizing the length of a patient's stay. 

Feb 20, 2020

CTC Enrichment Comparison Demonstrates Methods' Potential in Melanoma Patient Management

Premium

Angle's Parsortix yielded lower white blood cell backgrounds in samples, but Biolidics' ClearCell detected melanoma CTCs in additional samples that Parsortix missed. 

Feb 14, 2020

Amid Customer Complaints, Genetic Testing Firm Pathway OME Acquired by OME Wellness

Premium

Consumers have filed complaints about the San Diego-based firm's questionable business practices and lack of response in the last year. 

Feb 13, 2020

Following End of Qiagen Deal, HTG Molecular to Focus on CDx Plans and Other Alliances

Premium

HTG will leverage existing collaborations with firms including Illumina and Thermo Fisher Scientific to continue building in vitro diagnostic assays on their sequencers. 

Feb 10, 2020

Through Mayo Clinic Pact, PGDx Hopes to Show Clinical Utility for NGS Tissue, Liquid Biopsy Assays

Premium

The group envisions using PGDx's technology to identify effective therapy options for cancer patients and improve monitoring of patient response to therapy.

Feb 06, 2020

MD Anderson Researchers Using Liquid Biopsy to Predict Melanoma Relapse

Premium

The team plans to develop an assay that integrates circulating tumor cells and DNA to eliminate the need for repeated imaging surveillance in stage III melanoma patients. 

The Scan

Finds a Whole Bunch

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Away From the Field

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

PNAS Studies Look at Bacterial Detection Probes, Cholera Culprit Evolution in Environment, More

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

In a Different Lab

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.